Therapeutic Advances in Psychopharmacology
September 1, 2025
Sally Meikle, Olivia Carter, Paul Liknaitzky et al.
2 citations
Background: Depressive disorders are a major global health challenge, with many individuals unresponsive to existing treatments. Novel psychedelic therapies show promise but require further research. Objectives: This study aimed to evaluate the feasibility, safety and effectiveness of psilocybin with psychotherapeutic support for treatment-resistant depression (TRD), investigate predictors of...
ATHENS JOURNAL OF PHILOSOPHY
August 29, 2025
Oliver Thorndike
1 citation
This paper explores the potential for interdisciplinary collaboration between science and the humanities, with a focus on recent advancements in psychedelic-assisted therapy. It provides an overview of key concepts in this emerging field and identifies research gaps that offer opportunities for interdisciplinary integration. Adopting a non-reductionist naturalist framework, the paper views...
August 29, 2025
Romesha Uduwawela
<p><strong>Psilocybin, the psychoactive compound found in certain mushrooms, has gained increasing attention for its potential therapeutic applications in mental health treatment. While clinical research highlights its efficacy in alleviating mental disorders, such as depression, anxiety, PTSD, and substance use disorders, much remains to be known about the role of acute doses of psilocybin...
Translational Psychiatry
August 29, 2025
Anton L. V. Avanceña, Linh N. Vuong, James G. Kahn et al.
8 citations
Abstract Psilocybin-assisted therapy (PAT) has been shown in early trials to reduce the symptoms of treatment-resistant depression (TRD). This study evaluated the cost-effectiveness of PAT as a third-line treatment for major depressive disorder compared to standard of care (SOC). We used an individual-level, probabilistic simulation model that portrays representative US adults with TRD who...
Pharmaceutical Science
August 27, 2025
Guilllermo Castaño-perez, Sara Isabel Castaño-ocampo
The resurgence of research on the use of psychedelic substances for the treatment of mental disorders and addictions has generated significant interest in the scientific and clinical communities. This chapter examines the current evidence on the efficacy, safety, and limitations of psychedelics in the treatment of these conditions. Studies investigating the use of psychedelics as monotherapy...
Brain Sciences
August 21, 2025
Dean Bilenker, Nicole M. Avena
2 citations
Recent advances in psychedelic research have renewed interest in their therapeutic potential for psychiatric disorders characterized by cognitive and behavioral rigidity. This review examines the rationale for using serotonergic psychedelics—particularly 5-HT2A receptor agonists such as psilocybin—in the treatment of eating disorders (EDs), including anorexia nervosa (AN), bulimia nervosa (BN),...
NPP Digit Psychiatry Neurosci
August 20, 2025
Albert Garcia‐romeu
2 citations
Interest in “psychedelic therapies,” using substances such as ketamine, 3,4-methylenedioxymethamphetamine (MDMA), and psilocybin to treat psychiatric conditions, has grown steadily in recent years. Although pharmacologically distinct and functioning via differential mechanisms, these drugs are broadly classified as hallucinogenic, meaning they are thought to produce hallucinations. However,...
Frontiers in Psychiatry
August 19, 2025
Hebert W. Harris
This paper introduces Active Intersubjective Inference (AISI), a novel framework that integrates psychodynamic theory with predictive processing to explain self-identity construction and psychopathology. AISI posits that the self emerges from recursive inferences about how others perceive us (second-order self), interacting bidirectionally with interoceptive processes. We map psychodynamic...
Research Square
August 19, 2025
Haley D M Schuman, Julie M Deleemans, Tina Nguyen et al.
preprint
Abstract Background Psychedelic-assisted therapy (PAT) is gaining attention as a potential treatment for cancer-related psychosocial symptoms. While growing evidence highlights its promise, little is known about how different stakeholder groups perceive its use in oncology and palliative care. Objectives This study aimed to assess stakeholder-specific perspectives on PAT, including attitudes,...
Frontiers in Psychology
August 19, 2025
Matthew Goldreich
2 citations
This conceptual study examines Matte Blanco’s system of bi-logic as a novel framework for understanding psychedelic altered states of consciousness. The initial point of departure is a consideration of the complex historical relationship between psychoanalysis and psychedelics, prompting a review of contemporary psychoanalytic and neuropsychoanalytic perspectives on psychedelic action. This...